期刊文献+

腹膜透析清除钠的相关因素分析及其临床意义

Factors relating to sodium clearance in peritoneal dialysis and their clinical significance
下载PDF
导出
摘要 目的揭示腹膜透析患者钠清除的相关因素。方法 156例维持性腹膜透析患者,行改良腹膜平衡试验和透析充分性检查,对结果做多元线性回归分析。结果揭示了腹膜对钠清除的影响因素有透析剂量、每日净超滤量、血钠与新鲜透析液钠浓度差值和钠沉降率,总钠清除的影响因素有每日净超滤量、每日尿量、血钠与新鲜透析液钠浓度差值和钠沉降率。多元线性回归分析显示有显著相关性(P<0.01)。结论使用传统的腹膜透析液和足够的液体清除量是保证足够的钠清除量的最重要条件;使用低钠透析液应该是解决钠潴留的有效办法;评价透析充分性应包含钠清除的指标。 Objective To explore the factors relating to sodium clearance in peritoneal dialysis patients.Methods A total of 156 maintenance peritoneal dialysis patients who had completed the modified peritoneal equilibrium test(PET) and dialysis adequacy test were enrolled in this study.Multifactor regression analysis was used for data analysis.Results This study firstly disclosed the influence factors relating to the peritoneal sodium removal,including infusion volume and ultrafiltration every day,sodium dip during modified PET,and sodium concentration difference between serum and fresh dialysate.The influence factors relating to total sodium clearance included ultrafiltration every day,urine volume every day,sodium dip during modified PET,and sodium concentration difference between serum and fresh dialysate.Multifactor regression analysis indicated the presence of significant relationships.Conclusions(1) Sufficient fluid removal is necessary for adequate sodium removal when traditional dialysate is used;(2) Low sodium dialysate may be useful for the relief of sodium retention;(3) Index of sodium clearance should be included in the evaluation of dialysis adequacy.
出处 《中国血液净化》 2011年第5期262-264,共3页 Chinese Journal of Blood Purification
关键词 钠潴留 钠沉降率 透析充分性 腹膜平衡试验 Sodium retention Sodium dip Dialysis adequacy Peritoneal equilibration test
  • 相关文献

参考文献7

  • 1Krediet RT,Balafa O.Cardiovascular risk in the peritoneal dialysis patient.Nat Rev Nephrol,2010,6(8):451-460.
  • 2Wardener HE,He FJ,Macgregor GA.Plasma sodium and hypertension.Kidney Int,2004,66:2454-2466.
  • 3de Moraes TP,Pecoits-Filho R.Metabolic impact of peritoneal dialysis.Contrib Nephrol,2009,163:117-123.
  • 4Frampton JE,Plosker GL.Icodextrin:A Review of its Use in Peritoneal Dialysis.Drugs,2003,63(19):2079-2105.
  • 5单亦升,田信奎,汪涛.用动力学模型定量分析低钠透析液对钠清除量的影响[J].中国血液净化,2005,4(3):127-130. 被引量:3
  • 6单亦升,田信奎,汪涛.KT/Vurea和Ccr是否适合作为腹膜透析充分性指标的理论探讨[J].生物医学工程学杂志,2007,24(1):140-144. 被引量:8
  • 7Lo WK,Bargman JM,Burkart J,et al.Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis.Perit Dial Int,2006:26:520-522.

二级参考文献26

  • 1Davies SJ, Woodrow G, Donovan K, et al. Icodexitrin improves the fluid status of peritoneal dialysis patients: Results of a double- blind randomized controlled trial. J Am Soc Nephrol, 2003, 14:2338-2344
  • 2Nakayama M, Kawatuchi Y. Multicenter survey on hydration status and control of blood pressure in Japanses CAPD patients. Perit Dial Int,2002, 22:411-418
  • 3Rippe B. A three- pore model of peritoneal transport. Perit Dial Int,1992, 13 (1): S35-S38
  • 4Rippe B, Stelin G. Simulations of peritoneal solute transport during CAPD, application of two - pore formalism. Kidney International,1989, 35: 1234-1244
  • 5Rippe B, Stelin G, and Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney International, 1991, 40: 315-325
  • 6Amici G. Mathmatical models for prescription and delivery in peritoneal dialysis. Nephrol Dial Transplant, 1998, 13: 120-124
  • 7Locatelli F, Covic A, Chazot C et al. Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant, 2004, 19:1058- 1068
  • 8Churchill DN, Taylor DW, Keshaviah PR et al. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J AmSoc Nephrol, 1996, 7:198-207
  • 9Szeto CC, Wong TY, Chow KM, et al. Impact of dialysis adequacy in mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol, 2001, 12:43- 45
  • 10Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002,13: 1307- 1320

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部